US 8906413
Drug formulations having reduced abuse potential
granted A61KA61K31/00A61K31/137
Quick answer
US patent 8906413 (Drug formulations having reduced abuse potential) held by Supernus Pharmaceuticals, Inc. expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/00, A61K31/137, A61K31/485, A61K31/5513